$4.5 million going to Canastota as part of NY Forward program
CANASTOTA, N.Y. (WSYR-TV) — There is only one Thruway stop in Madison County, which brings you to Canastota. The historic village will soon get a major modern makeover as part of the New York Forward project.
'We had applied the first year and we weren't successful, so we sat down and read every winning application, and it took us a little over a year to put our application together once we understood a little bit more about what the state was looking for,' Canastota Mayor Roseanne Warner said.
The biggest chunk of the money will be spent on revitalizing a portion of the Erie Canal that still sits in the village. Some might call the walking path, canal front pavilion, and boat launch, among other things set to be installed, a 200th birthday gift for the Erie Canal.
'We hope that Canal Street itself will be the centerpiece because we are unique with this is the historic Erie canal, and it still rolls right through our village, and not too many people can say that,' Mayor Warner said.
Courtesy: Village of Canastota
Another large project is the renovation of the Canastota Fire House. One of the most significant additions will be an elevator, which will make the fire station ADA compliant.
'The building is in need of major repairs. Windows, doors, elevators, it's just going to enhance this community,' Doug Gustin, Deputy Mayor of the Village of Canastota, said.
Down at the end of East Center Street, where there is currently an empty lot, will be a Canal-side Pocket Neighborhood, which will feature about 51 new housing units.
'If you're a native of Canastota and you move away for five years and come back five years later, you're not going to recognize the place, it's going to be that transformative,' Jeremy Ryan, an administrator for the Village of Canastota, said.
Develop a Mixed-Use Pocket Neighborhood with Cafe Retail Space & Community Amenities on the Erie Canal ($500,000)
Expand ZEMS/Penny's to Create New Community Gathering Space South of the Canal ($239,000)
Convert the Vacant Canal Street Building into an NYS Farm Craft Brewing Facility ($575,000)
Transform the Vacant Historic Farr Building into Erie Canal Brewing Company Taproom & Village Welcome Center ($450,000)
Renovate Historic Building at 138 Canal Street for Commercial Use ($172,000)
Enhance North Canal Street to Improve Public Space, Walkability and Recreational Opportunities ($1,706,000)
Renovate Canastota Fire House for Improved Community Use & Greater Accessibility ($858,000)
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
Cardano's ADA Gains 3%, Buoyed by Inclusion in Nasdaq's Crypto Index
Cardano's native token ADA ADA added 3% in the past 24 hours after Nasdaq said it expanded its crypto benchmark index from five to nine assets, adding ADA alongside XRP XRP, Solana SOL and Stellar XLM. ADA experienced significant price volatility overnight, establishing a 8.8% trading range between $0.66 and $0.72, according to CoinDesk Research's technical analysis. It was recently trading at $0.6951. Trading volumes for ADA have increased 68% over the past 24 hours, suggesting active market participation despite uncertain conditions. Its addition to the Nasdaq index could significantly increase Cardano's visibility among traditional investors. Market analysts note the $0.70 level has emerged as a crucial psychological support zone that will likely determine ADA's short-term trajectory following its earlier bullish momentum. The CoinDesk 20 Index, which tracks the broader crypto market performance, is up about 4% over the past 24 hours. Technical Analysis ADA exhibited significant volatility over the 24-hour period, establishing a 8.8% trading range between $0.66 and $0.72 before dropping 3.3%. The price action formed a clear uptrend from $0.67 to $0.72 with strong volume support at the $0.68 level. The recent pullback from $0.72 to $0.69 suggests profit-taking after the rally, with the 0.70 level emerging as a key psychological support zone. Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Walton County to break ground on Driftwood Road
WALTON COUNTY, Fla. (WMBB) – The Walton County Board of County Commissioners and the Walton County Beach Operations and Tourism Departments plan to break ground on the Driftwood Road Municipal Parking facility. According to a news release, the construction will begin Monday, June 16, on 76 Driftwood Road in Miramar Beach at 9 a.m. U.S. 231 Road Improvement Project to begin in Bay County Walton County's need for public beach access, rest areas and transit stops led to the project approval from the BCC. The Driftwood Road Municipal Parking facility will include 67 parking spaces with dedicated ADA, LSV and bicycle parking. Four of the parking spots will also include electric vehicle charging stations. Officials say the construction of the 1.119-acre lot will take approximately 11 months. For visitors, the public transit stop will have air-conditioning as well as a restroom facility for convenience. The Tourist Development Tax, a 5% tax collected on short-term rentals in south Walton County, funds this development. For more information and project updates, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 days ago
- Yahoo
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetes SEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced an upcoming podium presentation highlighting ongoing clinical data from the investigator-sponsored, first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana's hypoimmune (HIP) technology, into a patient with type 1 diabetes without the use of any immunosuppression. The presentation will be held during a joint American Diabetes Association (ADA)/International Pancreas & Islet Transplant Association (IPITA) symposium at the 85th Annual ADA Scientific Sessions taking place June 20-23, 2025 in Chicago, IL. Presentation details: Symposium Title: Joint ADA/IPITA Symposium: Outpacing the Immune System—Sprinting Towards Immune Protection for Cell Replacement Therapy Presentation Title: Hypoimmune Pancreatic Islet Transplantation in Adult Subjects with Type 1 Diabetes Presentation Date: Monday, June 23, 2025 Presentation Time: 9:00 – 9:20 a.m. CT Location: W192 A-C About Sana Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, South San Francisco, CA and Bothell, WA. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements about Sana Biotechnology, Inc. (the 'Company,' 'we,' 'us,' or 'our') within the meaning of the federal securities laws, including those related to the company's vision and expectations regarding participation in and the presentation at the 85th Annual American Diabetes Association Scientific Sessions, including the content of such presentation. All statements other than statements of historical facts contained in this press release, including, among others, statements regarding the Company's strategy, expectations, cash runway and future financial condition, future operations, and prospects, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as 'aim,' 'anticipate,' 'assume,' 'believe,' 'contemplate,' 'continue,' 'could,' 'design,' 'due,' 'estimate,' 'expect,' 'goal,' 'intend,' 'may,' 'objective,' 'plan,' 'positioned,' 'potential,' 'predict,' 'seek,' 'should,' 'target,' 'will,' 'would,' and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results to vary materially, including, among others, the risks inherent in drug development such as those associated with the initiation, cost, timing, progress and results of the Company's current and future research and development programs, preclinical and clinical trials, as well as economic, market, and social disruptions. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's Securities and Exchange Commission reports, including but not limited to its Quarterly Report on Form 10-Q dated May 8, 2025. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason. Investor Relations & Media:Nicole